Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Pinzani

Showing results (61-70 of 216) with videos related to

Pageof 22
Sort By:
Journal of Hepatology|March 7, 2017
Reply to: "The BAVENO VI criteria to identify patients not requiring endoscopic surveillance for esophageal varices - Should We use it?"James Maurice, Massimo Pinzani, Emmanouil Tsochatzis, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|August 20, 2004
Hemodynamic derangement and cardiac dysfunction in cirrhosisPaolo Gentilini, Giorgio La Villa, Giacomo Laffi, et al.
Hepatology Communications|February 7, 2018
Liver tissue engineering: From implantable tissue to whole organ engineeringGiuseppe Mazza, Walid Al-Akkad, Krista Rombouts, et al.
Hepatology (Baltimore, Md.)|January 16, 2010
Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosisGuadalupe Garcia-Tsao, Scott Friedman, John Iredale, et al.
Gastroenterology|September 9, 2024
Portal Fibrosis and the Ductular Reaction: Pathophysiological Role in the Progression of Liver Disease and Translational OpportunitiesVikas Gupta, Tejasav S Sehrawat, Massimo Pinzani, et al.
World Journal of Gastroenterology|February 5, 2024
Portal hypertension in patients with nonalcoholic fatty liver disease: Current knowledge and challengesAnita Madir, Ivica Grgurevic, Emmanuel A Tsochatzis, et al.
United European Gastroenterology Journal|August 19, 2016
Biomarkers of intestinal fibrosis - one step towards clinical trials for stricturing inflammatory bowel diseasePaolo Giuffrida, Massimo Pinzani, Gino R Corazza, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 30, 2005
Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cellsPaola Brun, Ignazio Castagliuolo, Massimo Pinzani, et al.
Hepatology (Baltimore, Md.)|July 13, 2019
Defining the Minimum Acceptable Diagnostic Accuracy of Noninvasive Fibrosis Testing in Cirrhosis: A Decision Analytic Modeling StudyAvik Majumdar, Sara Campos, Kurinchi Gurusamy, et al.
Expert Opinion on Therapeutic Targets|September 14, 2023
Galectin-3: therapeutic targeting in liver diseaseAlison C Mackinnon, Dimitar Tonev, Brian Jacoby, et al.
Pageof 22

Showing results (61-70 of 216) with videos related to

Sort By:
Pageof 22
Journal of Hepatology|March 7, 2017
Reply to: "The BAVENO VI criteria to identify patients not requiring endoscopic surveillance for esophageal varices - Should We use it?"James Maurice, Massimo Pinzani, Emmanouil Tsochatzis, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|August 20, 2004
Hemodynamic derangement and cardiac dysfunction in cirrhosisPaolo Gentilini, Giorgio La Villa, Giacomo Laffi, et al.
Hepatology Communications|February 7, 2018
Liver tissue engineering: From implantable tissue to whole organ engineeringGiuseppe Mazza, Walid Al-Akkad, Krista Rombouts, et al.
Hepatology (Baltimore, Md.)|January 16, 2010
Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosisGuadalupe Garcia-Tsao, Scott Friedman, John Iredale, et al.
Gastroenterology|September 9, 2024
Portal Fibrosis and the Ductular Reaction: Pathophysiological Role in the Progression of Liver Disease and Translational OpportunitiesVikas Gupta, Tejasav S Sehrawat, Massimo Pinzani, et al.
World Journal of Gastroenterology|February 5, 2024
Portal hypertension in patients with nonalcoholic fatty liver disease: Current knowledge and challengesAnita Madir, Ivica Grgurevic, Emmanuel A Tsochatzis, et al.
United European Gastroenterology Journal|August 19, 2016
Biomarkers of intestinal fibrosis - one step towards clinical trials for stricturing inflammatory bowel diseasePaolo Giuffrida, Massimo Pinzani, Gino R Corazza, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 30, 2005
Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cellsPaola Brun, Ignazio Castagliuolo, Massimo Pinzani, et al.
Hepatology (Baltimore, Md.)|July 13, 2019
Defining the Minimum Acceptable Diagnostic Accuracy of Noninvasive Fibrosis Testing in Cirrhosis: A Decision Analytic Modeling StudyAvik Majumdar, Sara Campos, Kurinchi Gurusamy, et al.
Expert Opinion on Therapeutic Targets|September 14, 2023
Galectin-3: therapeutic targeting in liver diseaseAlison C Mackinnon, Dimitar Tonev, Brian Jacoby, et al.
Pageof 22